Inhibition of fear potentiated startle in rats following peripheral administration of secretin

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-003-1633-5PMID 14586542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NEUROANATOMICAL OBSERVATIONS OF THE BRAIN IN AUTISM

  2003cited by this paper
• A secretin i.v. infusion activates gene expression in the central amygdala of rats.

  2003cited by this paper
• Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety

  2002cited by this paper
• Differential Transport of a Secretin Analog across the Blood-Brain and Blood-Cerebrospinal Fluid Barriers of the Mouse

  2002cited by this paper
• In vitro autoradiographic localization of (125)i-secretin receptor binding sites in rat brain.

  2002cited by this paper
• Secretin as a neuropeptide

  2002cited by this paper
• The amygdala: vigilance and emotion

  2001cited by this paper
• Secretin Facilitates GABA Transmission in the Cerebellum

  2001influential reference
• Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.

  2001cited by this paper
• A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

  2001cited by this paper
• Convergent neuroanatomical and behavioural evidence of an amygdala hypothesis of autism

  2000cited by this paper
• Functional activities of the amygdala: an overview.

  2000cited by this paper
• The amygdala theory of autism.

  2000cited by this paper
• Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues.

  2000cited by this paper
• Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA

  2000cited by this paper
• LACK OF BENEFIT OF A SINGLE DOSE OF SYNTHETIC HUMAN SECRETIN IN THE TREATMENT OF AUTISM AND PERVASIVE DEVELOPMENTAL DISORDER

  2000cited by this paper
• Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

  1999cited by this paper
• The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans.

  1999cited by this paper
• Improved social and language skills after secretin administration in patients with autistic spectrum disorders.

  1998cited by this paper
• Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway.

  1995cited by this paper
• Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment

  1995cited by this paper
• cDNA sequence and genomic organization of mouse secretin.

  1994cited by this paper
• Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.

  1993cited by this paper
• Fear-potentiated startle: a neural and pharmacological analysis.

  1993cited by this paper
• Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors.

  1993cited by this paper
• Molecular cloning and expression of a cDNA encoding the secretin receptor.

  1991cited by this paper
• The secretin precursor gene. Structure of the coding region and expression in the brain.

  1991cited by this paper
• Neuroanatomic imaging in autism.

  1991cited by this paper
• The secretin gene: evolutionary history, alternative splicing, and developmental regulation.

  1991cited by this paper
• Secretin Stimulates Cyclic AMP Formation in the Rat Brain

  1986cited by this paper
• The design and calibration of a startle measurement system.

  1986influential reference
• Histoanatomic observations of the brain in early infantile autism

  1985cited by this paper
• Presence and possible site of action of secretin in the rat pituitary and hypothalamus.

  1984cited by this paper
• Secretin: specific binding to rat brain membranes

  1983cited by this paper
• Plasma gonadotropin, prolactin levels and hypothalamic tyrosine hydroxylase activity following intraventricular bombesin and secretin in ovariectomized conscious rats.

  1983cited by this paper
• Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.

  1980cited by this paper
• THE INFLUENCE OF SECRETIN, GLUCAGON AND OTHER PEPTIDES, OF AMINO ACIDS, PROSTAGLANDIN ENDOPEROXIDE ANALOGUES AND DIAZEPAM ON THE LEVEL OF ADENOSINE 3′,5′‐CYCLIC MONOPHOSPHATE IN NEUROBLASTOMA GLIOMA HYBRID CELLS

  1979cited by this paper
• Diazepam and flurazepam: Effects on conditioned fear as measured with the potentiated startle paradigm

  1979cited by this paper
• Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones.

  1979cited by this paper
• The mechanism of pancreatic secretion

  1902cited by this paper
• Mechanism of Pancreatic Secretion.

  year unknowncited by this paper

• Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies

  2023cites this paper
• Basic Neurobiology Techniques

  2020cites this paper
• Involvement of Secretin in the Control of Cell Survival and Synaptic Plasticity in the Central Nervous System

  2020cites this paper
• Assessment of Behavioral Dysfunction Following Experimental Traumatic Brain Injury (TBI)

  2019cites this paper
• Distribution and Functional Implication of Secretin in Multiple Brain Regions

  2018cites this paper
• Brain meets body: the blood-brain barrier as an endocrine interface.

  2012cites this paper
• Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

  2012cites this paper
• Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms.

  2009cites this paper
• A Functional Variable Number of Tandem Repeats is Located at the 5′ Flanking Region of the Human Secretin Gene Plays a Downregulatory Role in Expression

  2008cites this paper
• The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

  2008cites this paper
• Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans

  2008cites this paper
• Multiple actions of secretin in the human body.

  2008cites this paper
• AX+/BX- discrimination learning in the fear-potentiated startle paradigm in monkeys.

  2008cites this paper
• Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin

  2007cites this paper
• Secretin: A Pleiotrophic Hormone

  2006cites this paper
• Center for Behavioral Neuroscience: a prototype multi-institutional collaborative research center

  2006cites this paper
• Lack of effect of secretin on kindling and seizures.

  2006cites this paper
• Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin.

  2005cites this paper
• Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain.

  2004cites this paper
• Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent.

  2004cites this paper
• Transient expression of secretin in serotoninergic neurons of mouse brain during development

  2004cites this paper